Dental AI data residency—where your patient data is stored, processed, and legally governed—is one of the most consequential questions any practice should ask before signing an AI vendor contract. The answer determines your HIPAA exposure, your audit-readiness, and whether your Business Associate Agreement (BAA) will hold up under scrutiny. For institutions operating at the level of McGill, UCSF, or Harvard Medical School, it also governs cross-border compliance obligations that a standard BAA alone does not cover.
What dental AI data residency actually means
Data residency refers to the physical and jurisdictional location where data is stored and processed. For dental AI, that means: when AmbientVision™ captures a clinical encounter, or when your practice’s charting pipeline sends a note to be structured—where does that protected health information (PHI) actually travel?
Most vendors host on major cloud infrastructure: AWS, Azure, or GCP. The question is not which cloud—it is which region. A vendor whose servers sit in a US-East data center is subject to US jurisdiction and HIPAA. A vendor whose EU-based infrastructure processes US patient data may create transatlantic compliance exposure that requires additional contractual protections. For Canadian dental schools operating under provincial privacy law, this distinction is often the difference between a compliant deployment and a reportable incident.
There is also the question of data use. Residency covers where data lives. Practices should equally care about whether patient data is being used to train AI models—even in anonymized form. Most reputable vendors disclaim this explicitly in their Data Processing Agreement (DPA), but many do not. Absence of explicit contractual language is meaningful: it means the right is not waived.
A third dimension is data in transit. Even if a vendor’s primary storage is compliant, PHI traveling from your EHR to an AI processing layer and back must be encrypted end-to-end. Unencrypted API calls between system components are a common but underreported gap in dental AI compliance programs.
Questions to ask any dental AI vendor before you sign
When evaluating a dental AI tool, push for written answers to the following before committing:
- Where, exactly, are data stored? Require a region-level answer (e.g., “US-East-1 on AWS”), not a vague reference to “secure cloud infrastructure.”
- Will you execute a Business Associate Agreement? Under HIPAA, any vendor that processes PHI on your behalf must sign a BAA. The absence of a BAA offer is disqualifying.
- Who are your subprocessors? AI inference often runs through third-party APIs. Every subprocessor should be disclosed and covered under the BAA chain.
- Is patient data used to train models? Demand an explicit contractual prohibition, not just a verbal assurance.
- What is your data retention and deletion policy? Know how long PHI persists in the vendor’s systems after a session, and what happens to it when you terminate the contract.
- Do you hold a SOC 2 Type II report? This independent audit verifies that security controls are operating as designed, not just promised in a whitepaper.
These are not aggressive demands. They are baseline procurement hygiene for any software that touches PHI. The fact that many dental AI vendors cannot answer all six cleanly is itself informative about the state of the market.
How Rebrief approaches data residency
Rebrief was built for institutional dental environments where compliance documentation is not optional—it is reviewed by privacy officers, risk management teams, and in some cases ethics boards. That context shaped how the platform handles data from the ground up.
PHI processed through Rebrief—including clinical encounter data captured by AmbientVision and chart notes structured by the autonomous charting agent—resides in US-based infrastructure by default, with regional options available for Canadian and international institutions. Rebrief executes a BAA as a standard part of onboarding, not as a negotiated exception. The subprocessor list is disclosed and maintained, and patient data is never used for model training.
PracticeShield™, Rebrief’s chart-audit and denial-defense layer, is particularly relevant to compliance posture. Because PracticeShield operates on completed chart notes to identify documentation gaps before submission, the audit trail it generates becomes part of your defensible record—available for internal review and, if necessary, to respond to a payer audit or regulatory inquiry. That audit trail is governed by the same data residency commitments as the rest of the platform.
Integration with EHRs including Epic, Dentrix, Curve Dental, and Open Dental means data flows between Rebrief and your existing record system. Rebrief maps these integrations carefully, ensuring PHI in transit is encrypted and that the integration pathway is covered under the BAA. This is an area where many dental AI tools create silent compliance gaps—data leaves the EHR, passes through an AI layer, and returns without any contractual coverage of the intermediate step.
For practices evaluating the full Rebrief platform, the compliance documentation package—including the BAA template, DPA, and subprocessor disclosure—is available during the evaluation process, not after contract signature.
Institutions with specific cross-border requirements—Canadian dental schools, international research affiliates, or multi-jurisdiction academic medical centers—will want to explore the Enterprise tier. Rebrief Enterprise supports custom data residency configurations and is designed for deployments where a standard DPA is insufficient and where privacy impact assessments are required as part of institutional procurement. Tier details and enterprise options are on the pricing page.
Want a longer answer? Data residency requirements are specific to your jurisdiction, your EHR stack, and your patient population. The fastest route to written answers tailored to your situation is to schedule a conversation with the Rebrief team—we can walk through our compliance documentation and answer questions from your privacy officer directly.